Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

TIMOTHY L JACKSON

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1427070747
CMS profile
200771
Location
BEAVER, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$44.96

2 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $44.96 2

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Novo Nordisk Inc $23.34 1
ABBVIE INC. $21.62 1

Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

TIMOTHY L JACKSON

NPI 1427070747 · CMS profile ID 200771

Allopathic & Osteopathic Physicians / Internal Medicine

BEAVER, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1427070747?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
TIMOTHY L JACKSON, NPI 1427070747, CMS profile ID 200771. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1427070747?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). TIMOTHY L JACKSON, NPI 1427070747, CMS profile ID 200771. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1427070747?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
TIMOTHY L JACKSON, NPI 1427070747, CMS profile ID 200771, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1427070747?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

2 matching records · $44.96 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 2 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–2 of 2.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $21.6204/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103978502 CMS
Novo Nordisk Inc $23.3401/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097414233 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $260.46 19
PY2020 $195.47 12
PY2021 $95.34 6
PY2022 $222.89 13
PY2023 $111.20 6
PY2024 $44.96 2
PY2025 $109.48 5

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $503,145.38 229
PY2024 Principal investigator $594,169.25 24
PY2023 Principal investigator $199,257.41 109
PY2022 Principal investigator $75,190.78 47
PY2021 Principal investigator $41,602.59 77
PY2020 Principal investigator $45,172.38 58
PY2019 Principal investigator $122,329.81 53

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

53 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $795.96 12/19/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 692451041
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,418.00 12/18/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc. Attn: Julie White
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629164223
Principal investigator 1 SANOFI US SERVICES INC. $1,814.75 12/16/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function No dispute reported 06/30/2026 691605909
Principal investigator 1 Novo Nordisk AS $5,176.44 12/03/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 692451039
Principal investigator 1 SANOFI US SERVICES INC. $927.35 11/12/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function No dispute reported 06/30/2026 691605697
Principal investigator 1 SANOFI US SERVICES INC. $525.30 11/12/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function No dispute reported 06/30/2026 691605701
Principal investigator 1 SANOFI US SERVICES INC. $756.50 11/12/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function No dispute reported 06/30/2026 691605707
Principal investigator 1 SANOFI US SERVICES INC. $600.10 11/12/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function No dispute reported 06/30/2026 691605711
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,418.00 11/08/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc. Attn: Julie White
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629166589
Principal investigator 1 SANOFI US SERVICES INC. $1,814.75 11/04/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function No dispute reported 06/30/2026 691605527
Principal investigator 1 Novo Nordisk AS $1,954.80 10/29/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 692451027
Principal investigator 1 Avanir Pharmaceuticals, Inc. $7,162.50 10/23/2019 Non-covered Recipient Entity
HERITAGE VALLEY MEDICAL GROUP
15-AVP-786-302 No dispute reported 06/30/2026 656017011
Principal investigator 1 SANOFI US SERVICES INC. $787.95 10/15/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function No dispute reported 06/30/2026 691605351
Principal investigator 1 Novo Nordisk AS $11.41 09/25/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687397
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,104.00 09/17/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc. Attn: Julie White
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629162985
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,104.00 09/17/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc. Attn: Julie White
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629165729
Principal investigator 1 Novo Nordisk AS $2,000.00 09/10/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 692451033
Principal investigator 1 Avanir Pharmaceuticals, Inc. $7,156.25 08/29/2019 Non-covered Recipient Entity
HERITAGE VALLEY MEDICAL GROUP
15-AVP-786-302 No dispute reported 06/30/2026 656017009
Principal investigator 1 SANOFI US SERVICES INC. $756.50 08/28/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function No dispute reported 06/30/2026 691605129
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,104.00 08/26/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc. Attn: Julie White
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629163605
Principal investigator 1 SANOFI US SERVICES INC. $787.95 08/07/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function No dispute reported 06/30/2026 691604943
Principal investigator 1 SANOFI US SERVICES INC. $2,703.00 07/15/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function No dispute reported 06/30/2026 691604895
Principal investigator 1 Novo Nordisk AS $36.00 07/05/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687451
Principal investigator 1 Novo Nordisk AS $9.00 07/05/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687453
Principal investigator 1 Novo Nordisk AS $6.50 07/05/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687455
Principal investigator 1 Novo Nordisk AS $60.00 07/05/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687457
Principal investigator 1 Novo Nordisk AS $9.00 07/05/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687459
Principal investigator 1 Novo Nordisk AS $49.98 07/05/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687461
Principal investigator 1 Novo Nordisk AS $5.30 07/05/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687463
Principal investigator 1 Novo Nordisk AS $2.40 07/05/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687465
Principal investigator 1 Novo Nordisk AS $2.40 07/05/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687467
Principal investigator 1 Novo Nordisk AS $4.99 07/05/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687469
Principal investigator 1 Novo Nordisk AS $5.36 07/05/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687471
Principal investigator 1 Novo Nordisk AS $1.08 07/05/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687473
Principal investigator 1 Novo Nordisk AS $3.05 07/05/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687475
Principal investigator 1 Novo Nordisk AS $22.97 06/27/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
NN9535-4321 No dispute reported 06/30/2026 706687399
Principal investigator 1 Avanir Pharmaceuticals, Inc. $27,153.12 06/20/2019 Non-covered Recipient Entity
HERITAGE VALLEY MEDICAL GROUP
15-AVP-786-302 No dispute reported 06/30/2026 656017007
Principal investigator 1 SANOFI US SERVICES INC. $2,127.55 06/17/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardi No dispute reported 06/30/2026 691604748
Principal investigator 1 SANOFI US SERVICES INC. $2,869.60 06/17/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardi No dispute reported 06/30/2026 691609275
Principal investigator 1 SANOFI US SERVICES INC. $1,200.20 06/17/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardi No dispute reported 06/30/2026 691609279
Principal investigator 1 SANOFI US SERVICES INC. $6,939.40 06/17/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardi No dispute reported 06/30/2026 691609455
Principal investigator 1 SANOFI US SERVICES INC. $3,813.95 06/17/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardi No dispute reported 06/30/2026 691609791
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,104.00 06/12/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc. Attn: Julie White
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629163915
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,104.00 06/12/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc. Attn: Julie White
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629164831
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,104.00 05/16/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc. Attn: Julie White
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629165131
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $6,193.00 05/08/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc. Attn: Julie White
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629166307
Principal investigator 1 Novartis Pharmaceuticals Corporation $11,815.20 04/22/2019 Non-covered Recipient Entity
HERITAGE VALLEY INTERNAL MEDICINE
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED EVENT DRIVEN TRIAL OF QUARTERLY SUBCUTANEOUS CANAKINUMAB IN THE PREVENTION OF RECURRENT CARDIOVASCULAR EVENTS AMONG STABLE POST MYOCARDIAL INFARCTION PATIENTS WITH ELEVATED HSCRP No dispute reported 06/30/2026 640717237
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,063.00 02/12/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc. Attn: Julie White
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629165431
Principal investigator 1 Avanir Pharmaceuticals, Inc. $3,531.25 01/31/2019 Non-covered Recipient Entity
HERITAGE VALLEY MEDICAL GROUP
15-AVP-786-302 No dispute reported 06/30/2026 656017003
Principal investigator 1 Avanir Pharmaceuticals, Inc. $1,025.00 01/31/2019 Non-covered Recipient Entity
HERITAGE VALLEY MEDICAL GROUP
15-AVP-786-303 No dispute reported 06/30/2026 656017005
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,063.00 01/28/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc. Attn: Julie White
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629163295
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,063.00 01/28/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc. Attn: Julie White
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629164529
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $1,063.00 01/28/2019 Non-covered Recipient Entity
Heritage Valley Medical Group Inc. Attn: Julie White
BAY94-8862 ph 3 conventional in diabetic nephropathy No dispute reported 06/30/2026 629166023